2014 Q3 Form 10-K Financial Statement
#000114420414076185 Filed on December 29, 2014
Income Statement
| Concept | 2014 Q3 | 2014 | 2013 Q3 |
|---|---|---|---|
| Revenue | $20.00K | $135.1K | $50.00K |
| YoY Change | -60.0% | 3.21% | 66.67% |
| Cost Of Revenue | $0.00 | $73.00K | $40.00K |
| YoY Change | -100.0% | -47.86% | 100.0% |
| Gross Profit | $20.00K | $62.10K | $10.00K |
| YoY Change | 100.0% | -721.0% | |
| Gross Profit Margin | 100.0% | 45.97% | 20.0% |
| Selling, General & Admin | $610.0K | $2.424M | $780.0K |
| YoY Change | -21.79% | -16.45% | -9.3% |
| % of Gross Profit | 3050.0% | 3903.7% | 7800.0% |
| Research & Development | $310.0K | $1.455M | $430.0K |
| YoY Change | -27.91% | 12.77% | 152.94% |
| % of Gross Profit | 1550.0% | 2342.51% | 4300.0% |
| Depreciation & Amortization | $0.00 | $10.30K | $0.00 |
| YoY Change | -20.77% | -100.0% | |
| % of Gross Profit | 0.0% | 16.59% | 0.0% |
| Operating Expenses | $920.0K | $3.952M | $1.210M |
| YoY Change | -23.97% | -8.76% | 16.35% |
| Operating Profit | -$900.0K | -$3.817M | -$1.200M |
| YoY Change | -25.0% | -9.14% | 15.38% |
| Interest Expense | $20.00K | -$11.70K | -$70.00K |
| YoY Change | -128.57% | -99.09% | -101.32% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $40.00K | $1.162M | -$5.790M |
| YoY Change | -100.69% | -117.38% | -58000.0% |
| Pretax Income | -$840.0K | -$2.655M | -$7.060M |
| YoY Change | -88.1% | -75.61% | -265.73% |
| Income Tax | $0.00 | $5.200K | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$840.0K | -$2.663M | -$7.070M |
| YoY Change | -88.12% | -75.59% | -272.44% |
| Net Earnings / Revenue | -4200.0% | -1970.98% | -14140.0% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$10.50M | -$32.17M | -$35.35M |
| COMMON SHARES | |||
| Basic Shares Outstanding | 101.7M shares | 81.14M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2014 Q3 | 2014 | 2013 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $1.240M | $1.241M | $1.270M |
| YoY Change | -2.36% | -2.31% | 12600.0% |
| Cash & Equivalents | $1.241M | $1.274M | |
| Short-Term Investments | |||
| Other Short-Term Assets | $60.00K | $58.20K | $60.00K |
| YoY Change | 0.0% | -3.0% | 0.0% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $9.300K | $9.300K | $26.60K |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $1.308M | $1.308M | $1.364M |
| YoY Change | -4.09% | -3.82% | 1569.4% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $8.700K | $8.700K | $16.80K |
| YoY Change | -48.21% | -56.5% | -16.0% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $19.30K | $19.30K | $21.50K |
| YoY Change | -10.23% | -3.5% | -8.9% |
| Total Long-Term Assets | $28.00K | $28.00K | $38.30K |
| YoY Change | -26.89% | -30.0% | -12.16% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $1.308M | $1.308M | $1.364M |
| Total Long-Term Assets | $28.00K | $28.00K | $38.30K |
| Total Assets | $1.336M | $1.336M | $1.402M |
| YoY Change | -4.71% | -4.56% | 1019.07% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $868.9K | $868.9K | $2.493M |
| YoY Change | -65.15% | -65.1% | -19.23% |
| Accrued Expenses | $370.0K | $370.8K | $790.0K |
| YoY Change | -53.16% | -53.06% | -32.48% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $1.480M | $1.476M | $0.00 |
| YoY Change | -100.0% | ||
| Long-Term Debt Due | $3.500K | $3.500K | $7.200K |
| YoY Change | -51.39% | -65.0% | 38.46% |
| Total Short-Term Liabilities | $1.617M | $3.095M | $3.556M |
| YoY Change | -54.54% | -13.06% | -73.05% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $2.500K | $10.00K |
| YoY Change | -100.0% | -75.0% | 0.0% |
| Other Long-Term Liabilities | |||
| YoY Change | |||
| Total Long-Term Liabilities | $1.481M | $2.500K | $6.000K |
| YoY Change | 24581.67% | -75.0% | 20.0% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $1.617M | $3.095M | $3.556M |
| Total Long-Term Liabilities | $1.481M | $2.500K | $6.000K |
| Total Liabilities | $3.098M | $3.098M | $3.562M |
| YoY Change | -13.04% | -12.99% | -73.01% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$59.21M | -$56.55M | |
| YoY Change | 4.71% | 23.9% | |
| Common Stock | $101.7K | $92.70K | |
| YoY Change | 9.71% | 4778.95% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$1.762M | -$1.762M | -$2.160M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $1.336M | $1.336M | $1.402M |
| YoY Change | -4.71% | -4.56% | 1019.07% |
Cashflow Statement
| Concept | 2014 Q3 | 2014 | 2013 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$840.0K | -$2.663M | -$7.070M |
| YoY Change | -88.12% | -75.59% | -272.44% |
| Depreciation, Depletion And Amortization | $0.00 | $10.30K | $0.00 |
| YoY Change | -20.77% | -100.0% | |
| Cash From Operating Activities | -$730.0K | -$3.271M | -$1.000M |
| YoY Change | -27.0% | 7.74% | 156.41% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $0.00 | ||
| YoY Change | -100.0% | ||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Cash From Investing Activities | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $1.691M | ||
| YoY Change | -42.85% | ||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 1.900M | $3.332M | 1.590M |
| YoY Change | 19.5% | -22.91% | 297.5% |
| NET CHANGE | |||
| Cash From Operating Activities | -730.0K | -$3.271M | -1.000M |
| Cash From Investing Activities | 0.000 | $0.00 | 0.000 |
| Cash From Financing Activities | 1.900M | $3.332M | 1.590M |
| Net Change In Cash | 1.170M | $61.00K | 590.0K |
| YoY Change | 98.31% | -95.26% | 5800.0% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$730.0K | -$3.271M | -$1.000M |
| Capital Expenditures | $0.00 | ||
| Free Cash Flow | -$1.000M | ||
| YoY Change | 138.1% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2014 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Use of Estimates</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of the consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expense, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition, doubtful accounts, intangible assets, income taxes, valuation of equity instruments, accrued liabilities, contingencies and litigation. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013 | us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
130900 | USD |
| CY2014 | us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
135100 | USD |
| CY2014 | us-gaap |
Direct Operating Costs
DirectOperatingCosts
|
73000 | USD |
| CY2013 | cnso |
Product Development
ProductDevelopment
|
1119500 | USD |
| CY2013 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
347500 | USD |
| CY2014 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
390200 | USD |
| CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2554000 | USD |
| CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2034000 | USD |
| CY2013 | us-gaap |
Operating Expenses
OperatingExpenses
|
4331500 | USD |
| CY2014 | us-gaap |
Operating Expenses
OperatingExpenses
|
3951900 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4200600 | USD |
| CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3816800 | USD |
| CY2013 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-1288200 | USD |
| CY2014 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-11700 | USD |
| CY2013 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
556300 | USD |
| CY2014 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
1105200 | USD |
| CY2013 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
62100 | USD |
| CY2014 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
1800 | USD |
| CY2013 | us-gaap |
Debt Issuance Costs
DebtIssuanceCosts
|
2500 | USD |
| CY2014 | us-gaap |
Debt Issuance Costs
DebtIssuanceCosts
|
0 | USD |
| CY2013 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-97600 | USD |
| CY2014 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
26100 | USD |
| CY2013 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-6686600 | USD |
| CY2014 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1161900 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-10887200 | USD |
| CY2014 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-2654900 | USD |
| CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
800 | USD |
| CY2014 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
5200 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-10888000 | USD |
| CY2014 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-2660100 | USD |
| CY2013 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-19400 | USD |
| CY2014 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-2700 | USD |
| CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10907400 | USD |
| CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2662800 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
|
-0.14 | |
| CY2014 | us-gaap |
Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
|
-0.03 | |
| CY2013 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
|
-0.00 | |
| CY2014 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
|
-0.00 | |
| CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.14 | |
| CY2014 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.03 | |
| CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
75800179 | shares |
| CY2014 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
99326519 | shares |
| CY2014 | dei |
Entity Incorporation State Country Name
EntityIncorporationStateCountryName
|
Delaware | |
| CY2014 | dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
1987-03-20 | |
| CY2014 | us-gaap |
Property Plant And Equipment Depreciation Methods
PropertyPlantAndEquipmentDepreciationMethods
|
straight-line basis | |
| CY2013 | us-gaap |
Depreciation
Depreciation
|
13000 | USD |
| CY2014 | us-gaap |
Depreciation
Depreciation
|
10300 | USD |
| CY2013Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
64800 | USD |
| CY2014Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
75000 | USD |
| CY2013Q3 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
1 | |
| CY2014Q3 | us-gaap |
Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
|
501600 | USD |
| CY2013 | us-gaap |
Advertising Expense
AdvertisingExpense
|
14400 | USD |
| CY2014 | us-gaap |
Advertising Expense
AdvertisingExpense
|
3100 | USD |
| CY2013 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
76448279 | shares |
| CY2013 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
662300 | USD |
| CY2014Q3 | cnso |
Debt Instrument Conversion Vote Percentage
DebtInstrumentConversionVotePercentage
|
1 | pure |
| us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
76488279 | shares | |
| cnso |
Debt Conversion Original Debt Principal Amount
DebtConversionOriginalDebtPrincipalAmount
|
9613900 | USD | |
| CY2013 | cnso |
Debt Conversion Original Debt Principal Amount
DebtConversionOriginalDebtPrincipalAmount
|
9612100 | USD |
| cnso |
Debt Conversion Original Debt Interest Amount
DebtConversionOriginalDebtInterestAmount
|
1661100 | USD | |
| CY2013 | cnso |
Debt Conversion Original Debt Interest Amount
DebtConversionOriginalDebtInterestAmount
|
1661000 | USD |
| us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
11275000 | USD | |
| CY2013 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
11273100 | USD |
| CY2013 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1257300 | USD |
| CY2014 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1008700 | USD |
| CY2013Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1273600 | USD |
| CY2014Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1240600 | USD |
| CY2013Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
26600 | USD |
| CY2014Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
9300 | USD |
| CY2013Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
63700 | USD |
| CY2014Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
58200 | USD |
| CY2013Q3 | us-gaap |
Assets Current
AssetsCurrent
|
1363900 | USD |
| CY2014Q3 | us-gaap |
Assets Current
AssetsCurrent
|
1308100 | USD |
| CY2013Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
16800 | USD |
| CY2014Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
8700 | USD |
| CY2013Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
21500 | USD |
| CY2014Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
19300 | USD |
| CY2013Q3 | us-gaap |
Assets
Assets
|
1402200 | USD |
| CY2014Q3 | us-gaap |
Assets
Assets
|
1336100 | USD |
| CY2013Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2493200 | USD |
| CY2014Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
868900 | USD |
| CY2013Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
24200 | USD |
| CY2014Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
26200 | USD |
| CY2013Q3 | us-gaap |
Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
|
763100 | USD |
| CY2014Q3 | us-gaap |
Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
|
342000 | USD |
| CY2013Q3 | us-gaap |
Deferred Revenue
DeferredRevenue
|
0 | USD |
| CY2014Q3 | us-gaap |
Deferred Revenue
DeferredRevenue
|
45900 | USD |
| CY2013Q3 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
268500 | USD |
| CY2014Q3 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
177200 | USD |
| CY2013Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3556200 | USD |
| CY2014Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1616800 | USD |
| CY2013Q3 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
6000 | USD |
| CY2014Q3 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
2500 | USD |
| CY2013Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
6000 | USD |
| CY2014Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
1480900 | USD |
| CY2013Q3 | us-gaap |
Liabilities
Liabilities
|
3562200 | USD |
| CY2014Q3 | us-gaap |
Liabilities
Liabilities
|
3097700 | USD |
| CY2013Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
92700 | USD |
| CY2014Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
101700 | USD |
| CY2013Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
54298000 | USD |
| CY2014Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
57350200 | USD |
| CY2013Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-56550700 | USD |
| CY2014Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-59213500 | USD |
| CY2013Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2160000 | USD |
| CY2014Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1761600 | USD |
| CY2013Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1402200 | USD |
| CY2014Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1336100 | USD |
| CY2014Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
| CY2013Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2014Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
180000000 | shares |
| CY2014Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
101667409 | shares |
| CY2013Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
15000000 | shares |
| CY2013Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
360300 | USD |
| CY2014Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
3084425 | shares |
| CY2013Q1 | cnso |
Volume Of Shares Traded On Open Market
VolumeOfSharesTradedOnOpenMarket
|
283400 | USD |
| CY2012Q4 | cnso |
Volume Of Shares Traded On Open Market
VolumeOfSharesTradedOnOpenMarket
|
15000 | USD |
| CY2013Q4 | cnso |
Volume Of Shares Traded On Open Market
VolumeOfSharesTradedOnOpenMarket
|
180000 | USD |
| CY2013Q1 | cnso |
Volume Of Shares Traded On Open Market
VolumeOfSharesTradedOnOpenMarket
|
36700 | USD |
| CY2014Q3 | cnso |
Total Stock Shares Authorized
TotalStockSharesAuthorized
|
195000000 | shares |
| CY2013 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-10907400 | USD |
| CY2014 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-2662800 | USD |
| CY2014Q3 | us-gaap |
Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
|
3500 | USD |
| CY2014Q3 | us-gaap |
Capital Leases Future Minimum Payments Due In Two And Three Years
CapitalLeasesFutureMinimumPaymentsDueInTwoAndThreeYears
|
2500 | USD |
| CY2014Q3 | us-gaap |
Capital Leases Future Minimum Payments Due In Four And Five Years
CapitalLeasesFutureMinimumPaymentsDueInFourAndFiveYears
|
0 | USD |
| CY2014Q3 | us-gaap |
Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
|
0 | USD |
| CY2014Q3 | us-gaap |
Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
|
6000 | USD |
| CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
|
49200 | USD |
| CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Two And Three Years
OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears
|
18100 | USD |
| CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Four And Five Years
OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears
|
0 | USD |
| CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
0 | USD |
| CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
67300 | USD |
| CY2014Q3 | us-gaap |
Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
|
52700 | USD |
| CY2014Q3 | us-gaap |
Contractual Obligation Due In Second And Third Year
ContractualObligationDueInSecondAndThirdYear
|
20600 | USD |
| CY2014Q3 | us-gaap |
Contractual Obligation Due In Fourth And Fifth Year
ContractualObligationDueInFourthAndFifthYear
|
0 | USD |
| CY2014Q3 | us-gaap |
Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
|
0 | USD |
| CY2014Q3 | us-gaap |
Contractual Obligation
ContractualObligation
|
73300 | USD |
| CY2013 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
47700 | USD |
| CY2014 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
45000 | USD |
| CY2013Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
5900 | USD |
| CY2014Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1200 | USD |
| CY2013Q3 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
66700 | USD |
| CY2014Q3 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
41300 | USD |
| CY2013Q3 | cnso |
Deferred Compensation Liability Related Party Current
DeferredCompensationLiabilityRelatedPartyCurrent
|
294500 | USD |
| CY2014Q3 | cnso |
Deferred Compensation Liability Related Party Current
DeferredCompensationLiabilityRelatedPartyCurrent
|
71700 | USD |
| CY2013Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
| CY2013Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
92716562 | shares |
| CY2013Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
92716562 | shares |
| CY2014Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
101667409 | shares |
| CY2013 | us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
13000 | USD |
| CY2014 | us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
10300 | USD |
| CY2014 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
5000 | USD |
| CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1257300 | USD |
| CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1008700 | USD |
| CY2013 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
30400 | USD |
| CY2014 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
0 | USD |
| CY2013 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
622200 | USD |
| CY2014 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
2600 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
14200 | USD |
| CY2014 | cnso |
Stock Issued For Private Placement Shares Purchases
StockIssuedForPrivatePlacementSharesPurchases
|
1691000 | USD |
| CY2013 | cnso |
Stock Issued During Period Value Issued In Lieu Of Cash To Creditors
StockIssuedDuringPeriodValueIssuedInLieuOfCashToCreditors
|
502100 | USD |
| CY2014 | cnso |
Stock Issued During Period Value Issued In Lieu Of Cash To Creditors
StockIssuedDuringPeriodValueIssuedInLieuOfCashToCreditors
|
361500 | USD |
| CY2014 | cnso |
Stock Issued During Period Value Warrant Exercise
StockIssuedDuringPeriodValueWarrantExercise
|
0 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
7900 | USD |
| CY2014 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0.8pt 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>1.</b> <b>NATURE OF OPERATIONS</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0.8pt 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Organization and Nature of Operations</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="center"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>CNS Response, Inc. (“CNS,” “we,” “us,” “our,” or the “Company”) was incorporated in <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Delaware</font> on <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">March 20, 1987</font>, under the name Age Research, Inc.  Prior to January 16, 2007, the Company (then called Strativation, Inc.) was a “shell company” with nominal assets and our sole business was to identify, evaluate and investigate various companies to acquire or with which to merge.  On January 16, 2007, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with CNS Response, Inc., a California corporation formed on January 11, 2000 (“CNS California”), and CNS Merger Corporation, a California corporation and the Company’s wholly-owned subsidiary (“MergerCo”) pursuant to which the Company agreed to acquire CNS California in a merger transaction wherein MergerCo would merge with and into CNS California, with CNS California being the surviving corporation (the “Merger”). On March 7, 2007, the Merger closed, CNS California became a wholly-owned subsidiary of the Company, and on the same date the corporate name was changed from Strativation, Inc. to CNS Response, Inc.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company is a clinical decision support company with a patented commercial neurometric platform to predict drug response for the treatment of brain disorders, including depression, anxiety, bipolar disorder and post-traumatic stress disorder (“PTSD”).  The Company has commenced a reimbursed 2,000 patient trial at Walter Reed National Military Medical Center (“Walter Reed”) and Fort Belvoir Community Hospital (“Fort Belvoir”) focused on patients with depression, PTSD and mild traumatic brain injury in order to support clinical decisions in the treatment of depression and related disorders.  We are being reimbursed by Walter Reed at a study-specific rate which includes a prorated element for study expenses for each Psychiatric Electroencephalographic Evaluation Registry (“PEER”) Outcome report rendered in the study. Enrollment of study subjects commenced in May 2013, and has continued through May 15, 2014. On May 15, 2014, the study’s principal investigator was directed to suspend enrollment of new subjects into the study pending further investigation of findings stemming from a routine audit. Treatment and tracking of individuals already enrolled in the clinical trial were allowed to continue. The Company has been supporting Investigating Officer’s requests for information via the study leader, Dr. Brett Schneider. We have been advised by WRNMMC leadership that the investigation should complete during August 2014 and study enrollment should resume shortly thereafter.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company acquired the Neuro-Therapy Clinic, Inc. (“NTC”) on January 15, 2008, to provide behavioral health care services.  NTC’s operations were discontinued effective September 30, 2012. <i>(Refer to Note 3. Discontinued Operations).</i></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-SIZE: 10pt">  </font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">At the Company’s 2014 annual meeting of stockholders, held on May 13, 2014 (the “2014 Annual Meeting”), the Company’s common stockholders voted to reappoint the Company’s existing board of directors (the “Board”) to serve until the next annual meeting and until any successor is elected and qualified.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <i><font style="FONT-SIZE: 10pt"> </font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">Going Concern Uncertainty</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”), which contemplate continuation of the Company as a going concern. The Company has a limited operating history and its operations are subject to certain problems, expenses, difficulties, delays, complications, risks and uncertainties frequently encountered in the operation of a new business. These risks include the ability to obtain adequate financing on a timely basis, the failure to develop or supply technology or services to meet the demands of the marketplace, the failure to attract and retain qualified personnel, competition within the industry, government regulation and the general strength of regional and national economies.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company’s continued operating losses and limited capital raise substantial doubt about its ability to continue as a going concern. The Company has limited cash resources for its operations and will need to raise additional funds to meet its obligations as they become due.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">To date, the Company has financed its cash requirements primarily from debt and equity financings.  The Company will need to raise additional funds immediately to continue its operations and to raise substantial additional funds before the Company can increase demand for its PEER Online services (formerly known as rEEG services). Until it can generate a sufficient amount of revenues to finance its cash requirements, which it may never do, the Company has to finance future cash needs primarily through public or private equity offerings, debt financings, borrowings or strategic collaborations. The Company’s liquidity and capital requirements depend on several factors, including the rate of market acceptance of its services, the future profitability of the Company, the rate of growth of the Company’s business and other factors described elsewhere in this Annual Report on Form 10-K.  The Company continues to explore additional sources of capital but there is substantial doubt as to whether any financing arrangement will be available in amounts and on terms acceptable to the Company to permit it to continue operations. The accompanying audited consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Between October 4, 2013 and July 23, 2014, the Company issued an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 6,940,000</font> shares of its Common Stock, at a price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.25</font> per share, in private placements to an aggregate of 20 accredited investors. The gross proceeds to the Company were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,735,000</font>, net of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">44,000</font> in placement agent fees for net proceeds to the Company of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,691,000</font>. Furthermore between September 22 and 29, 2014 the Company issued secured convertible debt in the aggregate principal amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,650,000</font>. For the 2014 fiscal year the aggregate gross proceeds to the Company were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,385,000</font> from the combined equity and debt offerings. </font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2014 | us-gaap |
Stock Issued1
StockIssued1
|
361500 | USD |
| CY2012Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13074700 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1257300 | USD |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1008700 | USD |
| CY2013 | cnso |
Stock Issued For Private Placement Shares Purchases
StockIssuedForPrivatePlacementSharesPurchases
|
2958800 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-17300 | USD |
| CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
20000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-5500 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-63400 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-153900 | USD |
| CY2013 | us-gaap |
Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
|
30400 | USD |
| CY2014 | us-gaap |
Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
|
-421100 | USD |
| CY2013 | us-gaap |
Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
|
0 | USD |
| CY2014 | us-gaap |
Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
|
45900 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3036200 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3271100 | USD |
| CY2013 | us-gaap |
Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
|
1400 | USD |
| CY2014 | us-gaap |
Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
|
0 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
1400 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | USD |
| CY2013 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
4700 | USD |
| CY2014 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
7200 | USD |
| CY2013 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
1368300 | USD |
| CY2014 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
1648300 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
2958800 | USD |
| CY2014 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
1691000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4322400 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3332100 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
1287600 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
61000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
|
-21700 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
|
-94000 | USD |
| CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1265900 | USD |
| CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-33000 | USD |
| CY2012Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
7700 | USD |
| CY2013 | us-gaap |
Interest Paid Net
InterestPaidNet
|
3600 | USD |
| CY2014 | us-gaap |
Interest Paid Net
InterestPaidNet
|
4200 | USD |
| CY2013 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
800 | USD |
| CY2014 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
5200 | USD |
| CY2013 | cnso |
Shares Issued For Officer Salaries
SharesIssuedForOfficerSalaries
|
7900 | USD |
| CY2014 | cnso |
Shares Issued For Officer Salaries
SharesIssuedForOfficerSalaries
|
0 | USD |
| CY2014 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
0 | USD |
| CY2013 | us-gaap |
Stock Issued1
StockIssued1
|
502100 | USD |
| CY2014Q3 | cnso |
Deferred Tax Assets Net Before Valuation Allowance
DeferredTaxAssetsNetBeforeValuationAllowance
|
14617200 | USD |
| CY2013Q3 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
16546100 | USD |
| CY2013Q3 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2014Q3 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
14617200 | USD |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.034 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0062 | pure |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0142 | pure |
| CY2014 | us-gaap |
Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Deferred Revenue</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Deferred revenue represents revenue collected but not earned as of September 30, 2014. This represents a philanthropic grant for the payment of PEER Reports ordered for the Walter Reed clinical trial during calendar 2014, which are otherwise not paid for by Walter Reed or Fort Belvoir. These deferred revenue grant funds as of September 30, 2014, are $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">45,900</font>. As of September 30, 2013 there was no deferred revenue balance.  </font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2014Q3 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | USD |
| CY2014Q3 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
990600 | USD |
| CY2013Q3 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
0 | USD |
| CY2014Q3 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
153100 | USD |
| CY2013 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
0 | USD |
| CY2014 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
26100 | USD |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0079 | pure |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0176 | pure |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
| CY2014 | us-gaap |
Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
|
0 | USD |
| CY2014 | dei |
Document Type
DocumentType
|
10-K | |
| CY2014 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2014 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-09-30 | |
| CY2014 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
| CY2014 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2014 | dei |
Entity Registrant Name
EntityRegistrantName
|
CNS RESPONSE, INC. | |
| CY2014 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000822370 | |
| CY2014 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--09-30 | |
| CY2014 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2014 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2014 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2014 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2014Q1 | dei |
Entity Public Float
EntityPublicFloat
|
28787500 | USD |
| CY2014 | dei |
Trading Symbol
TradingSymbol
|
CNSO | |
| CY2013 | cnso |
Effective Income Tax Rate Reconciliation Extinguishment Of Debt
EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebt
|
-0.020 | pure |
| CY2014 | cnso |
Effective Income Tax Rate Reconciliation Extinguishment Of Debt
EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebt
|
0.015 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.030 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.05 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.090 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.340 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.340 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.030 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
-0.002 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
|
0.040 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
|
0 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.17 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
3.8 | pure |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.16 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
3.93 | pure |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.29 | pure |
| CY2014Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
0.21 | |
| CY2013Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
15370600 | USD |
| CY2014Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
13083200 | USD |
| CY2013Q3 | us-gaap |
Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
|
1168300 | USD |
| CY2014Q3 | us-gaap |
Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
|
1529800 | USD |
| CY2013Q3 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
2900 | USD |
| CY2014Q3 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
0 | USD |
| CY2013Q3 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
4300 | USD |
| CY2014Q3 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
5800 | USD |
| CY2013Q3 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
16546100 | USD |
| CY2014Q3 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
14618800 | USD |
| CY2013Q3 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
0 | USD |
| CY2014Q3 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
1600 | USD |
| cnso |
Stock Traded Value
StockTradedValue
|
277636 | USD | |
| CY2013Q3 | cnso |
Deferred Tax Assets Net Before Valuation Allowance
DeferredTaxAssetsNetBeforeValuationAllowance
|
16546100 | USD |
| CY2014Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
101667409 | shares |
| CY2013Q3 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
7200 | USD |
| CY2014Q3 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
3500 | USD |
| CY2013Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013 | us-gaap |
Other Income
OtherIncome
|
0 | USD |
| CY2014 | us-gaap |
Other Income
OtherIncome
|
44100 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
30400 | USD |
| CY2013 | cnso |
Stockissued During Period Value Conversion Of Convertible Senior Subordinated Securities
StockissuedDuringPeriodValueConversionOfConvertibleSeniorSubordinatedSecurities
|
3789200 | USD |
| CY2013 | cnso |
Stockissued During Period Value Conversion Of Convertible Subordinated Securities One
StockissuedDuringPeriodValueConversionOfConvertibleSubordinatedSecuritiesOne
|
3000600 | USD |
| CY2013 | cnso |
Stock Issued During Period Value Conversion Of Convertible Subordinated Securities Two
StockIssuedDuringPeriodValueConversionOfConvertibleSubordinatedSecuritiesTwo
|
2301400 | USD |
| CY2013 | cnso |
Stock Issued During Period Value Conversion Of Convertible Unsecured Securities One
StockIssuedDuringPeriodValueConversionOfConvertibleUnsecuredSecuritiesOne
|
101900 | USD |
| CY2014Q3 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2014 | us-gaap |
Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
|
As the original conversion terms of the notes were at $1 into one share of common stock with a fair value of $0.25, consequently, the three additional shares offered on conversion at $0.25 each represent the inducement to convert. | |
| CY2013 | us-gaap |
Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
|
5792500 | USD |
| CY2013 | cnso |
Stock Issued During Period Value Conversion Of Convertible Unsecured Securities Two
StockIssuedDuringPeriodValueConversionOfConvertibleUnsecuredSecuritiesTwo
|
2080000 | USD |
| CY2013Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
|
0 | USD |
| CY2014Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
|
2600 | USD |
| CY2013Q3 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
0 | USD |
| CY2014Q3 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
1475800 | USD |
| CY2014Q3 | us-gaap |
Convertible Debt
ConvertibleDebt
|
1475800 | USD |
| CY2014Q3 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
153100 | USD |
| CY2014Q3 | cnso |
Liabilities Carrying Value
LiabilitiesCarryingValue
|
1628900 | USD |
| CY2013Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
5900 | USD |
| CY2014Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
1200 | USD |
| CY2014Q3 | cnso |
Accounts Payable Writebacks
AccountsPayableWritebacks
|
44000 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
5792500 | USD |
| CY2013Q3 | cnso |
Debt Instrument Conversion Vote Percentage
DebtInstrumentConversionVotePercentage
|
1 | pure |
| CY2013 | cnso |
Shares Issued For Cashless Exercise Of Warrants
SharesIssuedForCashlessExerciseOfWarrants
|
0 | USD |
| CY2014 | cnso |
Shares Issued For Cashless Exercise Of Warrants
SharesIssuedForCashlessExerciseOfWarrants
|
600 | USD |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.269 | pure |
| CY2012Q4 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
556300 | USD |
| CY2013Q3 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
0 | USD |
| CY2014Q3 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
174200 | USD |
